Registration Dossier
Registration Dossier
Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.
The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.
Use of this information is subject to copyright laws and may require the permission of the owner of the information, as described in the ECHA Legal Notice.
EC number: 220-036-2 | CAS number: 2611-82-7
Endpoint summary
Administrative data
Description of key information
LD50 > 8000 mg/kg
LD0 = 8000 mg/kg
Key value for chemical safety assessment
Acute toxicity: via oral route
Endpoint conclusion
- Endpoint conclusion:
- no adverse effect observed
Acute toxicity: via inhalation route
Endpoint conclusion
- Endpoint conclusion:
- no study available
Acute toxicity: via dermal route
Endpoint conclusion
- Endpoint conclusion:
- no study available
Additional information
Based on literature data (Gaunt 1967), the substance is non toxic upon acute administration by oral route to rats and mice. In particular, no deaths were seen up to the highest tested dose.
Therefore, LD0 is 8000 mg/kg and LD50 > 8000 mg/kg.
Systemic effects were reported as slight colouration of animals, faeces and urine as well as lethargy for a few hours upon administration.
In the same study (Gaunt 1967), acute intraperitoneal toxicity was also assessed showing: LD50 = 600 mg/kg in male rats and 2600 mg/kg in female rats; LD50 = 1900 mg/kg in male mice and LD50 = 1600 mg/kg in female mice. Rapid uptake and distribution of the substance was seen. At necropsy, kidneys were pale and speckeld; tubular necrosis was seen, starting to recover within the 7 days observation period.
A study on acute inhalation toxicity was not conducted, based on particle size of the substance, i.e. a powder form with small fraction of inhalable particles, and negligible vapour pressure.
A study on acute dermal toxicity was not conducted, due to the low potential for dermal absorption along with the low acute toxicity observed by oral route. Absorption is expected to be higher orally than dermally.
Justification for classification or non-classification
According to the CLP Regulation (EC 1272/2008), 3.1 Acute toxicity section, substances can be allocated to one of four toxicity categories based on acute toxicity by the oral, dermal or inhalation route according to the numeric criteria. Acute toxicity values are expressed as (approximate) LD50 (oral, dermal) or LC50 (inhalation) values or as acute toxicity estimates (ATE).
The oral LD50 value was established to be greater than any classification limit for acute oral toxicity (oral acute toxicity category 4: 300 < ATE ≤ 2000 mg/kg bw).
No classification for acute dermal and inhalation toxicity was applied, based on considerations on physicochemical properties and absorption rate.
In conclusion, the substance does not meet the criteria to be classified for oral and dermal acute toxicity, according to the CLP Regulation (EC 1272/2008).
Information on Registered Substances comes from registration dossiers which have been assigned a registration number. The assignment of a registration number does however not guarantee that the information in the dossier is correct or that the dossier is compliant with Regulation (EC) No 1907/2006 (the REACH Regulation). This information has not been reviewed or verified by the Agency or any other authority. The content is subject to change without prior notice.
Reproduction or further distribution of this information may be subject to copyright protection. Use of the information without obtaining the permission from the owner(s) of the respective information might violate the rights of the owner.
